Healthcare · Drug Manufacturers Specialty Generic · NASDAQ
Indivior Pharmaceuticals, Inc. (INDV) is a Healthcare company in the Drug Manufacturers Specialty Generic industry. It has a market capitalization of $4.27B, a trailing price-to-earnings ratio of 9.9 and a free-cash-flow yield of -2.0%. Over the most recent reported fiscal year, revenue grew 4.3% and free cash flow per share fell 2042.5%.